VTGN
Vistagen Therapeutics Inc.
$3.85
-$0.19(-4.59%)
59
Overall
60
Value
83
Tech
36
Quality
Market Cap
$121.49M
Volume
261.53K
52W Range
$1.90 - $4.39
Target Price
$13.00
EPS Estimates Overview
| Current Quarter | $-0.52 | Next Quarter | $-0.36 |
| Current Year | $-1.67 | Next Year | $-1.9 |
| QoQ Growth | +30.8% | YoY Growth | -13.8% |
| 3Y EPS CAGR | +39.4% | Target Price | $13.00 |
| Consensus | Buy | Upside | +238.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VTGN | $3.85 | -4.6% | 261.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vistagen Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW